These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26362747)

  • 21. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
    Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
    Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of hepatitis B virus reactivation in patients with resolved infection on immunosuppressive therapy for rheumatic disease: a multicentre, prospective, observational study in Japan.
    Fukuda W; Hanyu T; Katayama M; Mizuki S; Okada A; Miyata M; Handa Y; Hayashi M; Koyama Y; Arii K; Kitaori T; Hagiyama H; Urushidani Y; Yamasaki T; Ikeno Y; Suzuki T; Omoto A; Sugitani T; Morita S; Inokuma S
    Ann Rheum Dis; 2017 Jun; 76(6):1051-1056. PubMed ID: 27934678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of tumor necrosis factor-alpha-blocking agents in hepatitis B virus-positive patients: reports of 3 cases and review of the literature.
    Zingarelli S; Frassi M; Bazzani C; Scarsi M; Puoti M; Airò P
    J Rheumatol; 2009 Jun; 36(6):1188-94. PubMed ID: 19447932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. JC virus reactivation in patients with autoimmune rheumatic diseases treated with rituximab.
    Domínguez-Mozo MI; Toledano-Martínez E; Rodríguez-Rodríguez L; García-Montojo M; Alvarez-Lafuente R; Fernández-Gutiérrez B
    Scand J Rheumatol; 2016 Nov; 45(6):507-511. PubMed ID: 27063911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenging Management of Hepatitis B infection in Ankylosing Spondylitis Patients in an Endemic Area during Immunosuppressive Therapy.
    Nunes GPS; Cunha PDS; Bosco DPD; Ribeiro SLE
    Rev Soc Bras Med Trop; 2019 Mar; 52():e20180386. PubMed ID: 30892401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term safety of rituximab in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection.
    Mitroulis I; Hatzara C; Kandili A; Hadziyannis E; Vassilopoulos D
    Ann Rheum Dis; 2013 Feb; 72(2):308-10. PubMed ID: 22930597
    [No Abstract]   [Full Text] [Related]  

  • 27. Targeted therapies in interstitial lung disease secondary to systemic autoimmune rheumatic disease. Current status and future development.
    Karakontaki FV; Panselinas ES; Polychronopoulos VS; Tzioufas AG
    Autoimmun Rev; 2021 Feb; 20(2):102742. PubMed ID: 33333235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biologic agents in the treatment of rheumatic diseases with chronic viral infection. Where are we?
    Wendling D; Di Martino V; Herbein G
    J Rheumatol; 2009 Jun; 36(6):1107-8. PubMed ID: 19509089
    [No Abstract]   [Full Text] [Related]  

  • 29. Rheumatologists' awareness of and screening practices for hepatitis B virus infection prior to initiating immunomodulatory therapy.
    Stine JG; Khokhar OS; Charalambopoulos J; Shanmugam VK; Lewis JH
    Arthritis Care Res (Hoboken); 2010 May; 62(5):704-11. PubMed ID: 20461789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis.
    Kohlmann R; Salmen A; Chan A; Knabbe C; Diekmann J; Brockmeyer N; Skaletz-Rorowski A; Michalik C; Gold R; Überla K
    Mult Scler; 2015 Dec; 21(14):1823-32. PubMed ID: 25828755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylaxis of hepatitis B reactivation with immunosuppressive therapy in rheumatic diseases. Orientations for clinical practice.
    Nunes J; Marinho RT; Fonseca JE; Pereira da Silva JA; Velosa J
    Acta Reumatol Port; 2011; 36(2):110-8. PubMed ID: 21841730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infection risk after orthopedic surgery in patients with inflammatory rheumatic diseases treated with immunosuppressive drugs.
    Scherrer CB; Mannion AF; Kyburz D; Vogt M; Kramers-de Quervain IA
    Arthritis Care Res (Hoboken); 2013 Dec; 65(12):2032-40. PubMed ID: 23861140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [How does one manage patients with rheumatoid arthritis and positive serology to hepatitis B, hepatitis C, human immunodeficiency virus?].
    Cabrera Villalba SR; Victoria Hernández Miguel M; Sanmartí Sala R
    Reumatol Clin; 2011; 7(3):203-7. PubMed ID: 21794814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of hepatitis B virus reactivation after anti-tumour necrosis factor treatment in potential occult carriers with chronic inflammatory arthropathies.
    Biondo MI; Germano V; Pietrosanti M; Canzoni M; Marignani M; Stroffolini T; Salemi S; D'Amelio R
    Eur J Intern Med; 2014 Jun; 25(5):482-4. PubMed ID: 24495663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of vaccinations and prophylaxis in rheumatic diseases.
    Papadopoulou D; Tsoulas C; Tragiannidis A; Sipsas NV
    Best Pract Res Clin Rheumatol; 2015 Apr; 29(2):306-18. PubMed ID: 26362746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should we routinely treat patients with autoimmune/rheumatic diseases and chronic hepatitis B virus infection starting biologic therapies with antiviral agents? Yes.
    Vassilopoulos D
    Eur J Intern Med; 2011 Dec; 22(6):572-5. PubMed ID: 22075282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rheumatic manifestations of hepatitis.
    Vassilopoulos D; Manolakopoulos S
    Curr Opin Rheumatol; 2010 Jan; 22(1):91-6. PubMed ID: 19864952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Managing varicella zoster virus contact and infection in patients on anti-rheumatic therapy.
    Cates M; Donati M; Gillet S; Ustianowski A; Galloway J
    Rheumatology (Oxford); 2018 Apr; 57(4):596-605. PubMed ID: 28575315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of vaccination in rheumatic disease.
    Wong PKK; Hanrahan P
    Best Pract Res Clin Rheumatol; 2018 Dec; 32(6):720-734. PubMed ID: 31427051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C-associated rheumatic disorders.
    Buskila D
    Rheum Dis Clin North Am; 2009 Feb; 35(1):111-23. PubMed ID: 19481000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.